Oncolytics Biotech, Inc. (ONCY) Q1 2026 Earnings
ONCY·Reported May 14, 2026·After market close
Diluted EPS came in at $-0.08 (-33.3% YoY), missed the $-0.05 consensus by $0.03.
Diluted EPS
$-0.08missed by $0.03
Consensus: $-0.05
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Oncolytics Biotech, Inc.'s Q1 2026 earnings report.
Oncolytics Biotech, Inc. (ONCY) reported Q1 2026 earnings on May 14, 2026 after market close.
Oncolytics Biotech, Inc. reported diluted EPS of $-0.08 for Q1 2026.
EPS missed the consensus estimate of $-0.05 by $0.03.
Compared to the same quarter a year prior, diluted EPS declined 33.3% from $-0.06.
You can read the 10-Q periodic report (0001129928-26-000033) directly on SEC EDGAR. The filing index links above go to sec.gov.